Page 48 - Anjali Singh

Max Healthcare Institute acquires Starlit Medical Centre for Rs 940 crore

Within its current network, it has 3,533 beds, and following this acquisition, the total bed count would approximately touch around 4,083 beds

GlaxoSmithKline completes VRS scheme as part of its business review

GlaxoSmithKline Pharmaceuticals has also established an Omnichannel Team, leveraging technology to enhance its reach and coverage across target segments

Luxury carmaker Lamborghini's Revuelto sold out in India, globally for 2026

Lamborghini is confident that its strong sales and investment in electrification will continue to drive its success in India and around the world

Lord's Mark Industries set to go public in 2024, aims to raise Rs 500 cr

IDBI Capital and Mirae Asset have been appointed as the merchant bankers for the listing

National TB elimination programme includes Mylab's advanced diagnostic kit

India carries a significant burden of TB cases, with the annual TB cases rising by 19 per cent in 2021

Bharat Biotech, University of Sydney ink MoU for vaccine research

The international agreement aims to foster strong collaborations between sectors and organisations to develop innovative methods for tackling future epidemics and infectious diseases

Musashi targets 25% market share in EV transmission components by 2028

This investment will be used to establish new assembly lines for EV transmission components and to upgrade existing facilities

Rusan Pharma Invests 300 Crores in New API Facility in MP's Pithampur

New plant to produce 400 MT of APIs, creating more than 300 jobs and enhancing global supply

BMC allocates Rs 1,500 crore for the upcoming healthcare schemes

BMC has also revealed that they are allocating Rs 3,500 crore for capital expenditure in the next couple of months and are planning to recruit 3,000 healthcare professionals

Ryzneuta for chemotherapy-induced neutropenia receives USFDA approval

Acrotech Biopharma is preparing to commercialise Ryzneuta in the United States in the near future

Pharma company Laurus Labs acquires 87.59% stake in Laurus Bio Private

The acquisition was made through a secondary purchase from the promoter group shareholders of Laurus Bio on November 20, 2023

India's workforce faces rising medical inflation, reveals report

The report also revealed nearly 59 per cent skip their annual health checkups, while 90 per cent neglect regular doctor consultations to monitor their health

Cipla's Pithampur unit gets USFDA warning; analysts remain bullish

The letter, dated November 17, 2023, highlights contraventions regarding methods or controls at the facility that do not conform to prescribed GMP regulations

Hero MotoCorp breaks festive sales record with over 1.4 mn units sold

Riding high on the success of the festival season, Hero MotoCorp has reduced its after-festival channel inventory to its lowest level in over three years

Dr Reddy's launches wearable device for drug-free management of migraine

In January this year, Dr Reddy's entered an exclusive agreement with Theranica for the marketing and distribution of Nerivio in India

Cipla concludes 51.18% stake sale in Ugandan subsidiary for $25 million

The sale was executed by Cipla (EU) Limited, UK, and Meditab Holdings Limited, Mauritius, both wholly-owned subsidiaries of Cipla Limited

Aster DM Healthcare Q2 results: Consolidated revenue rises 17.7%

On a sequential basis, the company exhibited a 3.15 per cent increase in revenue along with EBITDA, which grew 21 per cent year-on-year

Biocon Biologics targets top three biosimilar spot: Shreehas Tambe

The opportunity ahead of us is massive because over the next 10 odd years until 2032, we see 55 blockbuster molecules and biologics going out or losing exclusivity, says Tambe

Biocon biologics receives marketing approval by MHRA for YESAFILI in UK

This approval follows the green light granted by the European Commission (EC) for marketing authorisation in the European Union (EU) back in September

50% surge in diabetes in individuals under 40 yrs of age, say experts

Prevalence of diabetes no longer confined to just older demographics, Vitamin B12 deficiency may be a cause